Insulet | PODD - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.69M 193K 2026-06
AtriCure USD 394K 1.97M 2026-03
Baxter International USD 362M 368M 2026-06
Becton, Dickinson and Co. USD 39M 354M 2026-03
Boston Scientific USD 1.42B 261M 2026-06
Cardinal Health USD 782M 390M 2026-06
Cooper Companies USD -48.4M 240.6M 2026-03
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Globus Medical USD 157.07M 12.16M 2026-03
ICU Medical USD -3.97M 11.93M 2026-03
Inogen USD -6.06M 467K 2024-09
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
J&J USD 8.66B 839M 2026-06
Medtronic USD 2.26B 190M 2026-06
Merit Medical Systems USD 53.55M 2.49M 2026-03
Roche Holding CHF 11.17B 6.38B 2026-06
Solventum Corp USD 332M 179M 2025-12
Stryker USD 850M 855M 2026-03
Tandem Diabetes Care USD -19.88M 24.56M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
West Pharmaceutical Services USD 180.1M 18.6M 2026-03
Zimmer Biomet Holdings USD 487.5M 186.2M 2026-06